Medical Treatments for Prostate CancerThere are many different medical treatments for prostate cancer that involve the clinical care of a healthcare professional. These treatments include expectant therapy, surgery, radiation therapy, hormone therapy, and chemotherapy. Expectant therapy is to carefully observe and monitor the prostate cancer. Because prostate cancer cells often spread very slowly, many older men who have the disease may not need more extensive treatment. However, expectant therapy usually includes routine physician examinations, including digital rectal exams and PSA tests. The different types of surgery for prostate cancer are radical prostatectomy - an open-surgery procedure in which the entire prostate gland and surrounding tissue are removed. Transurethral resection of the prostate (TURP) - surgery to remove part of the prostate gland that surrounds the urethra. Cryosurgery - this procedure involves killing the cancer cells by freezing them with a small metal tool placed in the tumor. Side effects of prostate cancer surgery include incontinence and impotence. Incontinence is the inability to control urine and may result in dribbling of urine, especially immediately after surgery. Normal control usually returns within weeks or months after surgery. Impotence is the inability to achieve an erection. For a month, or so, after surgery, most men are not able to get an erection. Eventually, approximately 40 to 60 percent of men will be able to get an erection sufficient for sexual intercourse, but without ejaculation of semen, since removal of the prostate gland prevents that process.Radiation therapy uses high energy rays to kill or shrink cancer cells, and to decrease their ability to divide. Radiation is often used to treat prostate cancer that is still confined to the prostate gland, or has spread only to nearby tissue. If the disease is advanced, radiation may be used to reduce the size of the tumor and to provide relief from symptoms. Possible side effects of radiation for prostate cancer may include diarrhea, with or without blood in the stool, and colitis, problems associated with urination, a degree of impotence (inability to get an erection), which may occur within two years of radiation therapy. The goal of hormone therapy is to lower the level of male hormones in the body, particularly testosterone. Hormone therapy does not cure the cancer, and is often used to treat persons whose cancer has spread or recurred after treatment. Produced mainly in the testicles, testosterone causes prostate cancer cells to grow. Thus, reduced testosterone levels can make the prostate cancer shrink and become less active. Most studies show that hormone therapy works better if it is started early. Chemotherapy is the use of powerful, anti-cancer medications to kill cancer cells.. Hospitalization may be needed to monitor treatment and chemotherapy's side effects. Common side effects of chemotherapy include: nausea and vomiting, hair loss, anemia, reduced ability of blood to clot, mouth sores, increased likelihood of developing infections, fatigue. Most side effects disappear once treatment is stopped. |
| johns hopkins prostate cancer |
|
CHART PREDICTS WHETHER SURGERY WILL CURE PROSTATE CANCER Researchers at Johns Hopkins and other institutions have refined a chart that helps physicians determine how advanced a prostate cancer may be and guides Prostate-Help: Johns Hopkins Prostate Cancer Treatment Special Link: Johns Hopkins Prostate Cancer Treatment Special Report Released. The specialists at Johns Hopkins's world-renowned James Buchanan Brady Urological Atrasentan Reduces Risk of Prostate Canc Prostate Cancer Pill May Stave Off Disease and Ease Pain June 2004 Recent clinical studies led by Johns Hopkins Kimmel Cancer Center researchers have found Institute for NanoBioTechnology, Johns Hopkins University The etiological agents that cause prostate cancer remain unknown. There is emerging evidence that "risk factor" lesions that are proposed to represent Risk Factors for Prostate Cancer Researchers at Johns Hopkins and The Brady Urological Institute have three risk factors associated with death from prostate cancer after recurrence that Named Professorships, Deanships, and Directorships -- The Johns In Mr. Gerrard's family, diagnoses of prostate cancer have occurred in in pharmacology and molecular science from Johns Hopkins in 1984 and joined the Wake Forest-Johns Hopkins Team Discovers Prostate Cancer Gene Scientists in the Center for Human Genomics at Wake Forest University School of Medicine and Johns Hopkins Medical Institutions have discovered a gene that OBESITY-LINKED HIGH BLOOD VOLUMES RENDER PSA PROSTATE CANCER TEST The new research, combining data from more than 13000 prostate cancer patients at The Johns Hopkins Hospital and elsewhere, could eventually affect the EARLIER USE OF PROSTATE CANCER VACCINES URGED BY HOPKINS SCIENTISTS Johns Hopkins Medicine Office of Corporate Communications In the Hopkins studies with mice bred to develop prostate cancer, Drake and his collaborators Prostate Cancer: No One Answer for Testing or Treatment No One Improved screening tests and treatments for prostate cancer in very early But "nerve sparing" techniques developed at Johns Hopkins University have Johns Hopkins Gazette | April 30, 2007 New studies of a blood protein recently identified at Johns Hopkins, early prostate cancer antigen-2, or EPCA-2, may change the way men are screened for Johns Hopkins Researchers Present Advances In Prostate Cancer Ciphergen Biosystems,Inc. (Nasdaq: CIPH) announced the discovery of two biomarkers that may aidin the management of prostate cancer, including for the Johns Hopkins Gazette | September 26, 2005 PSA Best Indicator of Prostate Cancer Progression. By Eric Vohr Johns Hopkins Medicine. Despite recent claims by some urologists that measuring the blood The Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins Physicians hope to learn more about the incidence and risks of the disease through a registry of all Johns Hopkins prostate cancer patients, which has been The Sidney Kimmel Comprehensive Cancer Center At Johns Hopkins Welcome to the Prostate Cancer and other Genitourinary Cancers Program at the Johns Hopkins Kimmel Cancer Center. The experts at the Johns Hopkins Kimmel Johns Hopkins - Brady Urological Institute- Prostate Cancer Discovery Prostate Cancer Discovery -A PUBLICATION OF THE PATRICK C.WALSH PROSTATE CANCER RESEARCH FUND. Prostate Disorders, Prostate Cancer, BPH | Benign Prostatic Johns Hopkins Health Alerts: Prostate Disorders provides the latest research on the diagnosis and treatment of Benign Prostatic Hyperplasia (BPH), Johns Hopkins Health Alerts Is there a history of prostate cancer in your family and if so, what should you do? In this Q & A from an issue of the Johns Hopkins Prostate Bulletin Dr. Brady Urological Institute - Johns Hopkins Hospital The Brady Urological Institute of Johns Hopkins Hospital is dedicated to providing H. Ballentine Carter About Prostate Cancer · Expectant Management |
| johns hopkins prostate cancer |
|
pittsburgh prostate massage massage prostate sensual milking prostate pictures prostate awareness week |